CCI
PBYI icon

Columbus Circle Investors’s Puma Biotechnology PBYI Stock Holding History

Columbus Circle Investors’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-17,921
Closed -$667K – 280
2017
Q1 		$667K Buy
+17,921
New +$654K 0.01% 262
2016
Q1 		– Sell
-272,517
Closed -$21.4M – 300
2015
Q4 		$21.4M Buy
272,517
+179,885
+194% +$14.1M 0.17% 133
2015
Q3 		$6.98M Buy
92,632
+25,552
+38% +$2.42M 0.06% 210
2015
Q2 		$7.83M Sell
67,080
-135,931
-67% -$24.6M 0.06% 221
2015
Q1 		$47.9M Buy
203,011
+2,848
+1% +$609K 0.33% 78
2014
Q4 		$37.9M Buy
200,163
+115,511
+136% +$25.6M 0.27% 91
2014
Q3 		$20.2M Sell
84,652
-233,977
-73% -$48M 0.15% 138
2014
Q2 		$21M Sell
318,629
-40,860
-11% -$2.91M 0.14% 142
2014
Q1 		$37.4M Buy
359,489
+71,615
+25% +$8.42M 0.25% 103
2013
Q4 		$29.8M Buy
287,874
+278,884
+3,102% +$16.4M 0.2% 129
2013
Q3 		$482K Buy
8,990
+92
+1% +$4.96K ﹤0.01% 286
2013
Q2 		$395K Buy
+8,898
New +$314K ﹤0.01% 269

Other funds holding PBYI

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Columbus Circle Investors's PBYI Position: Q2 2017 in Review

Columbus Circle Investors sold out of Puma Biotechnology (PBYI) in Q2 2017, closing a stake of 17,921 shares — an estimated $667K sold.

Columbus Circle Investors first reported a position in PBYI in Q2 2013 and held it in 12 quarters. The position peaked at $47.9M in Q1 2015. 154 funds tracked by Wall St. Rank hold PBYI as of Q2 2017.

  • Columbus Circle Investors reported no remaining Puma Biotechnology position as of Q2 2017 after selling out during the quarter.
  • Columbus Circle Investors sold 17,921 Puma Biotechnology shares in Q2 2017, an estimated $667K.
  • Columbus Circle Investors first reported a position in Puma Biotechnology in Q2 2013 and held it in 12 quarters.
  • Columbus Circle Investors's Puma Biotechnology position peaked at $47.9M in Q1 2015.
  • 154 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2017.

Based on Columbus Circle Investors's 13F filing for Q2 2017, filed 4 Aug 2017.